Pro Medicus Limited (ASX:PME) is a Melbourne-based software owner and developer, licensing products to large US hospitals and Australian radiology clinics. The company has offices in Richmond, Victoria, Berlin, Germany and in the United States.
The Pro Medicus Ltd (ASX:PME) share price is down despite announcing some positive news from the FDA.
The S&P/ASX 200 (INDEXASX:XJO) is set to rise at the open on Tuesday. JB Hi-Fi (ASX:JBH) and QBE Insurance (ASX:QBE) shares are in the news.
The S&P/ASX 200 (INDEXASX:XJO) is expected to edge lower when the market opens on Friday. Afterpay (ASX:APT) and Pro Medicus (ASX:PME) shares are in the news.
Pro Medicus Ltd (ASX:PME) has won another contract in the US, from Intermountain Healthcare. Are Pro Medicus shares a buy?
The Pro Medicus Ltd (ASX:PME) share price is up another 3.5% today after another contract win.
Tony Hansen from EGP Capital takes in depth look at the future of Redbubble Ltd (ASX: RBL), given his past experiences with near $10 billion plumbing business Reece Group Ltd (ASX: REH).
Pro Medicus Ltd (ASX:PME) has announced another contract win in Europe, with a large German university hospital.
Pro Medicus Ltd (ASX:PME) has announced today that it continues to win market share in the US after winning a contract with NYU Langone Health.
In the second installment of our ASX Reporting Season Results Recap, myself and Wattle Partners financial adviser Drew Meredith, look at the reports from EML Payments Ltd (ASX:EML), Kogan.com Ltd (ASX:KGN), Pro Medicus Ltd (ASX:PME) and JB Hi-Fi Limited (ASX:JBH).
